Evidence map›Paper›PMID 33744668›Full record

Trial reportThe International journal on drug policy2021

Association of skin infections with sharing of injection drug preparation equipment among people who inject drugs.

Raagini Jawa, Michael D Stein, Bradley Anderson, Jane M Liebschutz, Catherine Stewart, Kristina T Phillips, Joshua A Barocas

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in The International journal on drug policy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Observational
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 1 country.

Raagini JawaSection of Infectious Diseases, Boston Medical Center, 801 Massachusetts Ave, 2nd floor, Boston 02118, MA, USA. Electronic address: raagini.jawa@bmc.org.
Michael D SteinBoston University School of Public Health, Boston, MA, USA; Behavioral Medicine and Addictions Research, Butler Hospital, Providence, RI, USA.
Bradley AndersonBehavioral Medicine and Addictions Research, Butler Hospital, Providence, RI, USA.
Jane M LiebschutzDivision of General Internal Medicine, Center for Research on Health Care, University of Pittsburgh, Pittsburgh, PA, USA.
Catherine StewartBoston University School of Public Health, Boston, MA, USA.
Kristina T PhillipsCenter for Integrated Health Care Research, Kaiser Permanente Hawaii.
Joshua A BarocasSection of Infectious Diseases, Boston Medical Center, 801 Massachusetts Ave, 2nd floor, Boston 02118, MA, USA; Boston University School of Medicine, Boston, MA, USA.
Boston Medical Center · USBoston University · USKaiser Permanente Center for Health Research · USProvidence College · USUniversity of Pittsburgh · US

Funding

BU Clinical HIV/AIDS Research Training Program (BU-CHART)T32AI052074 · NIAID · BOSTON UNIVERSITY MEDICAL CAMPUS · PI Benjamin P. Linas · 2003 to 2026
$6.7M
Advancing Clinical Research Training within Addiction Residency ProgramsR25DA033211 · NIDA · BOSTON MEDICAL CENTER · PI Patrick O'Connor, JEFFREY H. SAMET · 2012 to 2026
$4.2M
Preventing Bacterial and Viral Infections among Injection Drug UsersR01DA034957 · NIDA · BUTLER HOSPITAL (PROVIDENCE, RI) · PI STEIN, MICHAEL D · 2013 to 2017
$2.4M
Development of a novel community-based high-performance surveillance network for drug useDP2DA051864 · NIDA · UNIVERSITY OF COLORADO DENVER · PI BAROCAS, JOSHUA ADAM · 2020 to 2020
$2.3M
Strategies to reduce serious bacterial infections and overdose among people who inject drugsK01DA051684 · NIDA · UNIVERSITY OF COLORADO DENVER · PI BAROCAS, JOSHUA ADAM · 2020 to 2024
$809k
NIAID NIH HHS T32 AI052074NIDA NIH HHS DP2 DA051864NIDA NIH HHS K01 DA051684NIDA NIH HHS R01 DA034957NIDA NIH HHS R25 DA033211
6 · The paper itself

Abstract

backgroundSharing needles and injection drug preparation equipment (IDPE) among people who inject drugs (PWID) are well-established risk factors for viral transmission. Shared needles and IDPE may serve as bacterial niduses for skin and soft tissue infections (SSTI). Given the rising rates of SSTI in PWID, we investigated the association of needle and IDPE sharing on incidence of SSTI in a cohort of PWID.

methodsInpatient PWID (N = 252) were recruited to a randomized controlled trial of an intervention aimed at reducing infections. The primary outcome was self-reported incidence of SSTI one-year post-hospitalization. In this secondary analysis, we assessed two variables: 1) sharing of IDPE alone, 2) sharing needles with or without IDPE, and compared these groups separately to persons who reported no sharing of needles or IDPE via a mixed-effects negative binomial regression model to estimate the effect of baseline sharing behavior on SSTI during follow-up via incidence rate ratios (IRR).

resultsParticipant characteristics: 38 years [mean], 58% male, 60% White, 90% primarily injected opioids, 1.58 (± 2.35) mean SSTI in the year prior to baseline. In terms of sharing behavior, 29% didn't share needles or IDPE, 13% shared IDPE only, and 58% shared needles with or without IDPE three months prior to baseline. After adjusting for co-variables, PWID who shared IDPE alone had a 2.2 fold higher IRR of SSTI (95%CI 1.27; 3.85, p = 0.005) and PWID who shared needles with or without IDPE had a 3.31 fold higher IRR of SSTI (95%CI 2.04; 5.37, p < 0.001), compared to those who did not share any equipment. The number of SSTI at baseline was associated with an IRR of 1.20 of SSTI during follow-up (95%CI 1.09; 1.32, p < 0.001).

conclusionsIn this cohort of hospitalized PWID, we found a significant association between baseline sharing of IDPE alone and of sharing of needles with or without IDPE with one-year incidence of SSTI.

Indexed as

HIV InfectionsPharmaceutical PreparationsSoft Tissue InfectionsSubstance Abuse, IntravenousDrug CompoundingFemaleHumansInjectionsMaleNeedle SharingRisk-TakingPharmaceutical PreparationsBacterial infectionsHarm reductionInjection drug useInjection equipmentSkin infection

Identifiers

PMID33744668
PMCPMC8373634
OpenAlexW3137913487

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.